SAN DIEGO, Dec. 21 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. today announced that Dr. James R. Gavin III was elected to the company’s Board of Directors on December 16. Dr. Gavin will serve on Amylin’s Nominating and Governance Committee.
“We’re thrilled to welcome Dr. Gavin to the Amylin Board,” said Ginger L. Graham, President and CEO of Amylin Pharmaceuticals. “His extensive diabetes knowledge, distinguished academic career, and substantial board and governance experiences will be a tremendous asset to Amylin’s Board of Directors.”
Dr. Gavin currently serves as Clinical Professor of Medicine at Emory University School of Medicine and is Executive Vice President for Clinical Affairs for Healing Our Village, Inc. He also serves as National Director of the Harold Amos Medical Faculty Development Program. He previously held numerous research and academic positions including Senior Scientific Officer at the Howard Hughes Medical Institute (HHMI) and Director of the HHMI-National Institutes of Health Research Scholars Program. Dr. Gavin was also the William K. Warren Professor for Diabetes Studies and Acting Chief, Section of Endocrinology, Metabolism, and Hypertension at the University of Oklahoma Health Sciences Center.
He has served as president of the American Diabetes Association and on the editorial board of The American Journal of Physiology. Dr. Gavin is immediate Past Chair of the National Diabetes Education Program. He is also a member of the Institute of Medicine of the National Academies of Sciences and the recipient of numerous awards, including the Banting Medal for Distinguished Service from the American Diabetes Association. He serves as director for several organizations including Baxter International, Inc. and MicroIslets, Inc. and is a member of the Board of Trustees for Duke University, Livingstone College, and Emory University. Dr. Gavin received a B.S. in Chemistry from Livingstone College, a Ph.D. in biochemistry from Emory University, and an M.D. from Duke University.
Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development, and commercialization of innovative medicines.
Amylin Pharmaceuticals, Inc.
CONTACT: Mark Foletta, VP, Finance and CFO of Amylin Pharmaceuticals,Inc., +1-858-552-2200
